- Home
- AVXL vs ZEPP Comparison
AVXL vs ZEPP Comparison
Compare AVXL & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- ZEPP
- Stock Information
- Founded
- AVXL 2004
- ZEPP 2013
- Country
- AVXL United States
- ZEPP Netherlands
- Employees
- AVXL N/A
- ZEPP N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- ZEPP Computer Manufacturing
- Sector
- AVXL Health Care
- ZEPP Technology
- Exchange
- AVXL Nasdaq
- ZEPP Nasdaq
- Market Cap
- AVXL 635.6M
- ZEPP 696.3M
- IPO Year
- AVXL N/A
- ZEPP N/A
- Fundamental
- Price
- AVXL $3.71
- ZEPP $24.21
- Analyst Decision
- AVXL Strong Buy
- ZEPP
- Analyst Count
- AVXL 3
- ZEPP 0
- Target Price
- AVXL $33.00
- ZEPP N/A
- AVG Volume (30 Days)
- AVXL 2.9M
- ZEPP 375.9K
- Earning Date
- AVXL 12-22-2025
- ZEPP 11-04-2025
- Dividend Yield
- AVXL N/A
- ZEPP N/A
- EPS Growth
- AVXL N/A
- ZEPP N/A
- EPS
- AVXL N/A
- ZEPP N/A
- Revenue
- AVXL N/A
- ZEPP $233,274,000.00
- Revenue This Year
- AVXL N/A
- ZEPP $890.13
- Revenue Next Year
- AVXL N/A
- ZEPP $25.77
- P/E Ratio
- AVXL N/A
- ZEPP N/A
- Revenue Growth
- AVXL N/A
- ZEPP 11.64
- 52 Week Low
- AVXL $2.86
- ZEPP $2.13
- 52 Week High
- AVXL $14.44
- ZEPP $61.85
- Technical
- Relative Strength Index (RSI)
- AVXL 14.26
- ZEPP 28.65
- Support Level
- AVXL $6.35
- ZEPP $21.98
- Resistance Level
- AVXL $7.25
- ZEPP $29.00
- Average True Range (ATR)
- AVXL 0.64
- ZEPP 4.45
- MACD
- AVXL -0.34
- ZEPP -1.44
- Stochastic Oscillator
- AVXL 14.49
- ZEPP 8.63
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.